21st February 2022 | Pharma Updates
Submit Data on Safety of Ropivacaine: CDSCO Asks Cipla
The drug major presented the report of the phase III trial of the Ropivacaine hydrochloride monohydrate solution for infusion at 2 milligram/millilitre before the SEC of Central Drug Standard Control Organization.
Bharat Biotech's Vaccine to be Evaluated as Covid-19 Vaccine Candidate in USA as FDA Removes Clinical Hold
Covaxin is an investigational vaccine candidate product in the United States of America.
Nigeria to Receive Vaccine Production Facility
Nigeria, Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia have been chosen as the first six African countries that will get the technology needed to make mRNA-based vaccines.
Novavax first and second shots available for Mildura and Red Cliffs
Around 55.2% of Victorians over 18 have had three doses of a Covid vaccine.
FDA Allows Export of AstraZeneca's Vaccine
According to the American drug regulator, drugmaker’s vaccines made at Emergent BioSolutions plant are good to ship outside the US.
Inhaled drug is essential for at-home Covid treatment
United Pharm has developed incrementally modified drugs and is planning to launch inhaled Covid treatment.
FDA considering second Covid booster dose: Report
US drug regulator has been reviewing data to approve second booster shots of vaccines from Pfizer and BioNTech and Moderna.
Clinical Trials of ArCov Cancelled In Nepal
Vaccinemaker had partnered with Deurali-Janta Pharma to conduct phase 3 clinical trials in Nepal.
Livzon Pharma's Covid vaccine as a booster dose presents efficacy against omicron infection
The phase 3 clinical trial focuses to examine the efficacy, safety and immunogenicity of V-01 as a booster dose in adults above 18 after they have received two shots of inactivated vaccines.
More booster doses are on the way
The Commonwealth of the Northern Mariana Islands community can expect another phase of booster doses, as per the Commonwealth Healthcare Corporation.
You must be logged in to post a comment.